Non-stationarity and power spectral shifts in EMG activity reflect motor unit recruitment in rat diaphragm muscle. (73/98)

 (+info)

Therapeutic effects of beta1, 4 mannobiose in a Balb/c mouse model of intranasally-induced pollen allergy. (74/98)

 (+info)

Exposure to influenza virus aerosols during routine patient care. (75/98)

 (+info)

Airflow dynamics of human jets: sneezing and breathing - potential sources of infectious aerosols. (76/98)

 (+info)

Comparison of the levels of infectious virus in respirable aerosols exhaled by ferrets infected with influenza viruses exhibiting diverse transmissibility phenotypes. (77/98)

 (+info)

The internet, adolescent males, and homemade blowgun darts: a recipe for foreign body aspiration. (78/98)

 (+info)

A case report of diffuse pneumocephalus induced by sneezing after brain trauma. (79/98)

Pneumocephalus is the presence of air in the cranial vault. The common etiologies of pneumocephalus are brain trauma and cranial surgery. We report a case of a 26-year-old man with brain trauma who developed diffuse pneumocephalus after sneezing. CT scan was performed on arrival, and the image showed subarachnoid hemorrhage without pneumocephalus. On the seventh day after a big sneeze brain CT scan was re-performed, which showed pneumocephalus. After another ten days of treatment, the patient was discharged without any symptoms.  (+info)

Nasal challenge with ragweed pollen in hay fever patients. Effect of immunotherapy. (80/98)

Challenge of the nasal mucosa of allergic subjects with specific allergen induces not only the expected sneezing and rhinorrhea, but also the appearance in nasal secretions of mediators commonly associated with activation of mast cells or basophils: histamine, leukotrienes, prostaglandin D2 (PGD2), kinins, and TAME ([3H]-N-alpha-tosyl-L-arginine methyl ester)-esterase. To determine whether specific immunotherapy alters mediator release in vivo, nasal pollen challenge was used to compare 27 untreated highly sensitive ragweed (RW)-allergic subjects with 12 similarly sensitive patients receiving long-term immunotherapy (3-5 yr) with RW extract (median dose, 6 micrograms RW antigen E). The two groups were equally sensitive based on skin tests and basophil histamine release. The immunized group had a diminished response as demonstrated by (a) the treated group required higher pollen doses to excite sneezing or mediator release; (b) significantly fewer subjects in the treated group released mediators at any dose (TAME-esterase [P = 0.005], PGD2 [P = 0.04]), and (c) the treated group released 3-5-fold less mediator (TAME-esterase [P = 0.01], and histamine [P = 0.02]).  (+info)